These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28957812)

  • 1. Humoral Immune Response in Mice Elicited by Combined Yeast-Derived Hepatitis B Virus Core, Surface, and Mosaic Surface Antigens.
    Granovski V; Yokosawa J; Rodrigues-Granovski V; Castro CC; Urbina AC; Granovski N
    Intervirology; 2017; 60(3):90-101. PubMed ID: 28957812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.
    Heijtink RA; Bergen Pv; Melber K; Janowicz ZA; Osterhaus AD
    Vaccine; 2002 May; 20(17-18):2191-6. PubMed ID: 12009272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
    Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT; Floreani M; Tyner J; Whitters E; Rosenlof R; Wray L; Goetze A; Sarin V; Eble K
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
    Chen X; Li M; Le X; Ma W; Zhou B
    Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
    Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological cross-reactivity between preS2 sequences of the hepatitis B virus envelope proteins corresponding to serological subtypes adw2 and ayw.
    Neurath AR; Kent SB; Adamowicz P; Riottot MM; Price P; Strick N; Parker K; Petit MA; Budkowska A; Girard M
    Mol Immunol; 1987 Jun; 24(6):561-8. PubMed ID: 3657796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of oral tolerance towards hepatitis B envelope antigens in a murine model.
    Gotsman I; Beinart R; Alper R; Rabbani E; Engelhardt D; Ilan Y
    Antiviral Res; 2000 Oct; 48(1):17-26. PubMed ID: 11080537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity pattern of monoclonal antibodies against Hepatitis B vaccine with global Hepatitis B virus genotypes.
    Golsaz-Shirazi F; Asadi-Asadabad S; Sarvnaz H; Mehdi Amiri M; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Shokri F
    Clin Chim Acta; 2020 Nov; 510():203-210. PubMed ID: 32679130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.
    Obeng-Adjei N; Hutnick NA; Yan J; Chu JS; Myles DJ; Morrow MP; Sardesai NY; Weiner DB
    Cancer Gene Ther; 2013 Dec; 20(12):652-62. PubMed ID: 24310062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
    Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1
    Pantazica AM; Dobrica MO; Lazar C; Scurtu C; Tucureanu C; Caras I; Ionescu I; Costache A; Onu A; Clarke JL; Stavaru C; Branza-Nichita N
    Front Immunol; 2022; 13():941243. PubMed ID: 35935966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B vaccine.
    Madaliński K; Sylvan SP; Hellstrom U; Mikołajewicz J; Dzierzanowska-Fangrat K
    Med Sci Monit; 2004 Jan; 10(1):PI10-7. PubMed ID: 14704645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.